{
  "company": {
    "name": "KaloCyte",
    "website": "https://kalocyte.com/",
    "record": "https://startuphistory.org/c/kalocyte.com"
  },
  "status": null,
  "history_since": "2018-03-21T19:13:43.000Z",
  "baseline": {
    "snapshot_id": "67edc22bb9c98aeedfa20b476195c08aea7ef828fab582012c03b4b7d51e822f",
    "observed_at": "2018-03-21T19:13:43.000Z",
    "headline": "A revolution in trauma care",
    "description": "Accuronix develops novel therapies that selectively target cells and deliver cytotoxic payloads, thereby increasing efficacy and reducing toxicity risk",
    "evidence": "https://web.archive.org/web/20180321191343/http://kalocyte.com:80/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:28:16.780Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2018-03-21T19:13:43.000Z",
      "variants": [
        {
          "headline": "A revolution in trauma care",
          "subhead": "Accuronix develops novel therapies that selectively target cells and deliver cytotoxic payloads, thereby increasing efficacy and reducing toxicity risk",
          "observed_at": "2018-03-21T19:13:43.000Z",
          "evidence": "https://web.archive.org/web/20180321191343/http://kalocyte.com:80/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "A revolution in trauma care",
      "subhead": "Accuronix develops novel therapies that selectively target cells and deliver cytotoxic payloads, thereby increasing efficacy and reducing toxicity risk",
      "from": "2018-03-21T19:13:43.000Z",
      "to": "2018-03-21T19:13:43.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20180321191343/http://kalocyte.com:80/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2018-03-21T19:13:43.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2024-01-05T20:29:50.000Z",
      "variants": [
        {
          "headline": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION",
          "subhead": null,
          "observed_at": "2019-07-05T05:47:27.000Z",
          "evidence": "https://web.archive.org/web/20190705054727/http://www.kalocyte.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION",
          "subhead": null,
          "observed_at": "2020-01-05T01:04:34.000Z",
          "evidence": "https://web.archive.org/web/20200105010434/http://www.kalocyte.com:80/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION",
          "subhead": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION Discover ErythroMer™ KaloCyte is developing ErythroMer, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when",
          "observed_at": "2021-10-24T22:09:00.000Z",
          "evidence": "https://web.archive.org/web/20211024220900/https://www.kalocyte.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION",
          "subhead": null,
          "observed_at": "2022-08-07T05:12:35.000Z",
          "evidence": "https://web.archive.org/web/20220807051235/https://www.kalocyte.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION",
          "subhead": null,
          "observed_at": "2023-03-07T00:27:47.000Z",
          "evidence": "https://web.archive.org/web/20230307002747/https://www.kalocyte.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION",
          "subhead": null,
          "observed_at": "2024-01-05T20:29:50.000Z",
          "evidence": "https://web.archive.org/web/20240105202950/https://www.kalocyte.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION",
      "subhead": null,
      "from": "2019-07-05T05:47:27.000Z",
      "to": "2024-01-05T20:29:50.000Z",
      "captures": 6,
      "evidence": "https://web.archive.org/web/20240105202950/https://www.kalocyte.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2019-07-05T05:47:27.000Z",
          "to": "2024-01-05T20:29:50.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:28:16.780Z",
      "variants": [
        {
          "headline": "Discover ErythroMer™",
          "subhead": "KaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.",
          "observed_at": "2025-02-07T13:20:03.000Z",
          "evidence": "https://web.archive.org/web/20250207132003/https://kalocyte.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Discover ErythroMer™",
          "subhead": "KaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.",
          "observed_at": "2025-07-24T10:22:46.000Z",
          "evidence": "https://web.archive.org/web/20250724102246/https://kalocyte.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Discover ErythroMer™",
          "subhead": "KaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.",
          "observed_at": "2026-09-15T11:22:22.000Z",
          "evidence": "https://web.archive.org/web/20260915112222/https://kalocyte.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Discover ErythroMer™",
          "subhead": "KaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.",
          "observed_at": "2026-11-06T17:28:16.780Z",
          "evidence": "https://kalocyte.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Discover ErythroMer™",
      "subhead": "KaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.",
      "from": "2025-02-07T13:20:03.000Z",
      "to": "2026-11-06T17:28:16.780Z",
      "captures": 4,
      "evidence": "https://kalocyte.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2025-02-07T13:20:03.000Z",
          "to": "2026-11-06T17:28:16.780Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-67edc22bb9c98aeedfa20b476195c08aea7ef828fab582012c03b4b7d51e822f:786774480506fc0736436f5b6d53531d42a8624045db78c9913b907e6f9d90d3:headline:13a68eef509c9ad8",
      "before_evidence": "https://web.archive.org/web/20180321191343/http://kalocyte.com:80/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “A revolution in trauma care” to “DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION”.",
      "between": {
        "from": "2018-03-21T19:13:43.000Z",
        "to": "2019-07-05T05:47:27.000Z"
      },
      "evidence": "https://web.archive.org/web/20190705054727/http://www.kalocyte.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 2,
      "id": "page-aa5b0cda6090453d7a1b6ded971add5fb348d37e6efdcad4f76058d361e6d7ea:3635be1bcdfba19c3fa9939a7421d3a4a49bb626a9d6f8f8ba0ebcd581c64e6e:headline:079c7ece6b5571c9",
      "before_evidence": "https://web.archive.org/web/20240105202950/https://www.kalocyte.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “DEVELOPING A SOLUTION FOR WHEN BLOOD IS NOT AN OPTION” to “Discover ErythroMer™”.",
      "between": {
        "from": "2024-01-05T20:29:50.000Z",
        "to": "2025-02-07T13:20:03.000Z"
      },
      "evidence": "https://web.archive.org/web/20250207132003/https://kalocyte.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “KaloCyte” company record, https://startuphistory.org/c/kalocyte.com"
}